Here's What Key Metrics Tell Us About Clarivate (CLVT) Q2 Earnings

Core Insights - Clarivate PLC (CLVT) reported revenue of $621.4 million for the quarter ended June 2025, reflecting a year-over-year decline of 4.4% and an EPS of $0.18 compared to $0.20 a year ago [1] - The reported revenue exceeded the Zacks Consensus Estimate of $590.76 million by 5.19%, while the EPS met the consensus estimate [1] Revenue Breakdown - Academia & Government revenues were $318.5 million, surpassing the average estimate of $308.52 million, but showing a year-over-year decline of 7.6% [4] - Intellectual Property revenues reached $202.5 million, exceeding the average estimate of $190.4 million, with a slight year-over-year increase of 0.5% [4] - Life Sciences & Healthcare revenues totaled $100.4 million, above the average estimate of $92.85 million, but down 3.7% year over year [4] - Subscription revenues were reported at $405.7 million, slightly above the average estimate of $402.83 million, with no year-over-year change [4] - Re-occurring revenues amounted to $108.9 million, close to the average estimate of $109.35 million, reflecting a year-over-year increase of 0.3% [4] - Transactional and other revenues were $106.8 million, significantly exceeding the average estimate of $74.37 million, but showing a substantial decline of 21.5% compared to the previous year [4] Stock Performance - Clarivate's shares have returned -6.2% over the past month, contrasting with the Zacks S&P 500 composite's increase of 3.4% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]